Literature DB >> 25599617

Clinical trials: New nonabsorbable potassium-exchange resins in hyperkalaemia.

Sara S Roscioni1, Hiddo J Lambers Heerspink2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25599617     DOI： 10.1038/nrneph.2014.252

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Combined angiotensin inhibition for the treatment of diabetic nephropathy.

Authors:  Linda F Fried; Nicholas Emanuele; Jane H Zhang; Mary Brophy; Todd A Conner; William Duckworth; David J Leehey; Peter A McCullough; Theresa O'Connor; Paul M Palevsky; Robert F Reilly; Stephen L Seliger; Stuart R Warren; Suzanne Watnick; Peter Peduzzi; Peter Guarino
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

2.  Sodium zirconium cyclosilicate in hyperkalemia.

Authors:  David K Packham; Henrik S Rasmussen; Philip T Lavin; Mohamed A El-Shahawy; Simon D Roger; Geoffrey Block; Wajeh Qunibi; Pablo Pergola; Bhupinder Singh
Journal:  N Engl J Med       Date:  2014-11-21       Impact factor: 91.245

3.  Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.

Authors:  Matthew R Weir; George L Bakris; David A Bushinsky; Martha R Mayo; Dahlia Garza; Yuri Stasiv; Janet Wittes; Heidi Christ-Schmidt; Lance Berman; Bertram Pitt
Journal:  N Engl J Med       Date:  2014-11-21       Impact factor: 91.245

4.  Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?

Authors:  Richard H Sterns; Maria Rojas; Paul Bernstein; Sreedevi Chennupati
Journal:  J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 10.121

5.  Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.

Authors:  Y Miao; D Dobre; H J Lambers Heerspink; B M Brenner; M E Cooper; H-H Parving; S Shahinfar; D Grobbee; D de Zeeuw
Journal:  Diabetologia       Date:  2010-09-30       Impact factor: 10.122

Review 6.  Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.

Authors:  Sara S Roscioni; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers Heerspink
Journal:  Nat Rev Nephrol       Date:  2012-10-16       Impact factor: 28.314

7.  The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.

Authors:  Hiddo J Lambers Heerspink; Peggy Gao; Dick de Zeeuw; Catherine Clase; Gilles R Dagenais; Peter Sleight; Eva Lonn; Koon T Teo; Salim Yusuf; Johannes F Mann
Journal:  Eur J Prev Cardiol       Date:  2013-11-04       Impact factor: 7.804

8.  Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Authors:  Hans-Henrik Parving; Barry M Brenner; John J V McMurray; Dick de Zeeuw; Steven M Haffner; Scott D Solomon; Nish Chaturvedi; Frederik Persson; Akshay S Desai; Maria Nicolaides; Alexia Richard; Zhihua Xiang; Patrick Brunel; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

9.  Telmisartan, ramipril, or both in patients at high risk for vascular events.

Authors:  Salim Yusuf; Koon K Teo; Janice Pogue; Leanne Dyal; Ingrid Copland; Helmut Schumacher; Gilles Dagenais; Peter Sleight; Craig Anderson
Journal:  N Engl J Med       Date:  2008-03-31       Impact factor: 91.245

10.  Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial.

Authors:  Mikhail Kosiborod; Henrik S Rasmussen; Philip Lavin; Wajeh Y Qunibi; Bruce Spinowitz; David Packham; Simon D Roger; Alex Yang; Edgar Lerma; Bhupinder Singh
Journal:  JAMA       Date:  2014-12-03       Impact factor: 56.272
  10 in total
  2 in total

1.  Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care.

Authors:  Michele Provenzano; Roberto Minutolo; Paolo Chiodini; Vincenzo Bellizzi; Felice Nappi; Domenico Russo; Silvio Borrelli; Carlo Garofalo; Carmela Iodice; Toni De Stefano; Giuseppe Conte; Hiddo J L Heerspink; Luca De Nicola
Journal:  J Clin Med       Date:  2018-12-01       Impact factor: 4.241

2.  Novel Bloodless Potassium Determination Using a Signal-Processed Single-Lead ECG.

Authors:  Zachi I Attia; Christopher V DeSimone; John J Dillon; Yehu Sapir; Virend K Somers; Jennifer L Dugan; Charles J Bruce; Michael J Ackerman; Samuel J Asirvatham; Bryan L Striemer; Jan Bukartyk; Christopher G Scott; Kevin E Bennet; Dorothy J Ladewig; Emily J Gilles; Dan Sadot; Amir B Geva; Paul A Friedman
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.